Express Healthcare
Home  »  News  »  La-med Healthcare eyes revenue of over Rs 100 crore in FY’21

La-med Healthcare eyes revenue of over Rs 100 crore in FY’21

The company further plans to expand its footprint to South America, Australia, New Zealand, South America, Peru, Chile, Panama and Mexico

0 66
Read Article

La-med Healthcare has said it is on track to achieve revenue of over Rs 100 crore in the 2021 fiscal, as it is all set to enter new and untapped global markets including South America, Australia, New Zealand, South America, Peru, Chile, Panama and Mexico.

The Faridabad-based company currently has a strong domestic as well as global distribution network. It manufactures and supplies affordable premium-quality medical devices such as needle-free connectors, ventilator circuits with combo kits, PTCA kits and anti-UV extension lines across India and in 55 countries across the globe. The company has adopted ISO 9001:2015 quality management system and ISO 13485:2016 quality management system, especially for medical devices. All La-Med products have a CE-marking from DNV GL PRESAFE Norway, a certification body, making it a trusted quality manufacturer of medical devices in major government hospitals and institutions pan-India and across the world. The company currently has a manufacturing plant in Faridabad, Haryana.

“We clocked revenue of Rs 20.5 crores in the last quarter and are on our way to achieve our target of Rs 100 crore for the FY’21 on the back of organic as well as inorganic expansion. In the coming years, our products will be available in new global territories that are currently untapped but have huge potential for a company like ours. We are also reviving up our manufacturing potential and are in the process of constructing another plant parallel to the existing facility by December 2020. We are optimistic that 2020 will be a conducive year for growth at La-Med,” said Mayank Lakhani, Managing Director, La-med Healthcare.

Leave A Reply

Your email address will not be published.

Webinar on COVID 19 Response Plan: Key lessons from the HIV epidemic
Register Now
close-image